Literature DB >> 32926123

Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing.

Fabienne Lucas1, Phillip D Michaels1,2, Dahai Wang1, Annette S Kim1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32926123      PMCID： PMC7509881          DOI： 10.1182/bloodadvances.2020002306

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  9 in total

1.  The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical Practice.

Authors:  Victoria Northrup; Allison Maybank; Nancy Carson; Tarek Rahmeh
Journal:  Am J Clin Pathol       Date:  2020-04-15       Impact factor: 2.493

2.  Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event.

Authors:  M Jawhar; J Schwaab; S Schnittger; K Sotlar; H-P Horny; G Metzgeroth; N Müller; S Schneider; N Naumann; C Walz; T Haferlach; P Valent; W-K Hofmann; N C P Cross; A Fabarius; A Reiter
Journal:  Leukemia       Date:  2015-01-08       Impact factor: 11.528

Review 3.  Clinical Significance of DNA Variants in Chronic Myeloid Neoplasms: A Report of the Association for Molecular Pathology.

Authors:  Rebecca F McClure; Mark D Ewalt; Jennifer Crow; Robyn L Temple-Smolkin; Mrudula Pullambhatla; Rachel Sargent; Annette S Kim
Journal:  J Mol Diagn       Date:  2018-08-20       Impact factor: 5.568

4.  Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.

Authors:  Jie He; Omar Abdel-Wahab; Michelle K Nahas; Kai Wang; Raajit K Rampal; Andrew M Intlekofer; Jay Patel; Andrei Krivstov; Garrett M Frampton; Lauren E Young; Shan Zhong; Mark Bailey; Jared R White; Steven Roels; Jason Deffenbaugh; Alex Fichtenholtz; Timothy Brennan; Mark Rosenzweig; Kimberly Pelak; Kristina M Knapp; Kristina W Brennan; Amy L Donahue; Geneva Young; Lazaro Garcia; Selmira T Beckstrom; Mandy Zhao; Emily White; Vera Banning; Jamie Buell; Kiel Iwanik; Jeffrey S Ross; Deborah Morosini; Anas Younes; Alan M Hanash; Elisabeth Paietta; Kathryn Roberts; Charles Mullighan; Ahmet Dogan; Scott A Armstrong; Tariq Mughal; Jo-Anne Vergilio; Elaine Labrecque; Rachel Erlich; Christine Vietz; Roman Yelensky; Philip J Stephens; Vincent A Miller; Marcel R M van den Brink; Geoff A Otto; Doron Lipson; Ross L Levine
Journal:  Blood       Date:  2016-03-10       Impact factor: 22.113

5.  Clinical utility of targeted next-generation sequencing-based screening of peripheral blood in the evaluation of cytopenias.

Authors:  Vignesh Shanmugam; Aric Parnes; Rajeshwari Kalyanaraman; Elizabeth A Morgan; Annette S Kim
Journal:  Blood       Date:  2019-12-12       Impact factor: 22.113

6.  Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies.

Authors:  Aaron M Goodman; Michael Choi; Matthew Wieduwilt; Carolyn Mulroney; Caitlin Costello; Garrett Frampton; Vincent Miller; Razelle Kurzrock
Journal:  JCO Precis Oncol       Date:  2017-04-27

Review 7.  Mutational profiling in patients with MDS: ready for every-day use in the clinic?

Authors:  Ulrike Bacher; Alexander Kohlmann; Torsten Haferlach
Journal:  Best Pract Res Clin Haematol       Date:  2014-11-12       Impact factor: 3.020

8.  Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.

Authors:  Michael J Kluk; R Coleman Lindsley; Jon C Aster; Neal I Lindeman; David Szeto; Dimity Hall; Frank C Kuo
Journal:  J Mol Diagn       Date:  2016-07       Impact factor: 5.568

Review 9.  Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use.

Authors:  Ulrike Bacher; Evgenii Shumilov; Johanna Flach; Naomi Porret; Raphael Joncourt; Gertrud Wiedemann; Martin Fiedler; Urban Novak; Ursula Amstutz; Thomas Pabst
Journal:  Blood Cancer J       Date:  2018-11-12       Impact factor: 11.037
  9 in total
  2 in total

1.  Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia.

Authors:  Lori Muffly; Vandana Sundaram; Connie Chen; Ilana Yurkiewicz; Eric Kuo; Sarah Burnash; Jay Y Spiegel; Sally Arai; Matthew J Frank; Laura J Johnston; Robert Lowsky; Everett H Meyer; Robert S Negrin; Andrew R Rezvani; Surbhi Sidana; Parveen Shiraz; Judith A Shizuru; Wen-Kai Weng; Michaela Liedtke; Hyma T Vempaty; David B Miklos
Journal:  Blood Adv       Date:  2021-08-24

2.  A predictive model for bone marrow disease in cytopenia based on noninvasive procedures.

Authors:  Dicte Træden; Morten Tulstrup; Jack Bernard Cowland; Lene Dissing Sjö; Martin Bøgsted; Kirsten Grønbæk; Mette Klarskov Andersen; Jakob Werner Hansen
Journal:  Blood Adv       Date:  2022-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.